Pfizer Gains China Approval for New Obesity Drug as Competition Intensifies in Growing Market
Pfizer has secured approval in China for its new obesity treatment ecnoglutide, according to Bloomberg News, marking the pharmaceutical giant's entry into a rapidly expanding weight management market already dominated by established players.